Chart: Biotech Stocks - SG&A Margin (MRQ)
-
Font Size:
Selling, General and Administrative Expenses (most recently reported quarter) as a percentage of total revenue in the Biotech sector ranged from 844.3% (ALXN) down to 7.0% (IMCL), with a median value of 42.3%.
Data in table version -- click on a ticker for opinion and analysis of the company:
| Total | SG&A | SG&A | |||
|---|---|---|---|---|---|
| Quarter | Revenue | Expense | Margin | ||
| Ticker | Company | Ending | ($mm) | ($mm) | (%) |
| AFFX | Affymetrix Inc. | 12/31/05 | $86.39 | $30.30 | 35.1%
|
| ALXN | Alexion Pharmaceuticals Inc. | 10/31/05 | $0.77 | $6.48 | 844.3%
|
| AMGN | Amgen Inc. | 12/31/05 | $3217.00 | $911.00 | 28.3%
|
| AMLN | Amylin Pharmaceuticals Inc. | 12/31/05 | $82.35 | $57.07 | 69.3%
|
| BIIB | Biogen Idec Inc. | 12/31/05 | $611.18 | $162.02 | 26.5%
|
| BMRN | BioMarin Pharmaceutical Inc. | 12/31/05 | $13.81 | $11.08 | 80.2%
|
| BSTE | Biosite Incorporated | 12/31/05 | $79.33 | $19.83 | 25.0%
|
| CELG | Celgene Corporation | 12/31/05 | $181.84 | $58.08 | 31.9%
|
| DNA | Genentech Inc. | 03/31/06 | $1986.00 | $474.00 | 23.9%
|
| ELN | Elan Corp. plc | 12/31/05 | $134.30 | $90.00 | 67.0%
|
| GILD | Gilead Sciences Inc. | 03/31/06 | $692.88 | $149.71 | 21.6%
|
| GPRO | Gen-Probe Inc. | 12/31/05 | $86.26 | $18.09 | 21.0%
|
| IMCL | Imclone Systems Inc. | 12/31/05 | $245.13 | $17.13 | 7.0%
|
| INCY | Incyte Corp. | 12/31/05 | $6.47 | $3.41 | 52.8%
|
| ISTA | ISTA Pharmaceuticals Inc. | 12/31/05 | $3.68 | $8.66 | 235.2%
|
| KOSP | KOS Pharmaceuticals Inc. | 12/31/05 | $213.92 | $100.99 | 47.2%
|
| MEDI | MedImmune Inc. | 03/31/06 | $498.00 | $217.90 | 43.8%
|
| NABI | Nabi Biopharmaceuticals | 12/31/05 | $27.55 | $17.19 | 62.4%
|
| NBIX | Neurocrine Biosciences Inc. | 12/31/05 | $19.48 | $13.94 | 71.6%
|
| ONXX | Onyx Pharmaceuticals Inc. | 12/31/05 | N/A | $17.76 | N/A
|
| PGNX | Progenics Pharmaceuticals Inc. | 12/31/05 | $2.05 | $4.18 | 204.1%
|
| PHRM | Pharmion Corp. | 12/31/05 | $56.59 | $23.14 | 40.9%
|
| TELK | Telik Inc. | 12/31/05 | N/A | $2.74 | N/A
|
| VRTX | Vertex Pharmaceuticals Inc. | 12/31/05 | $39.09 | $12.81 | 32.8% |
Data: Capital IQ
Related:
- Most recent opinion and analysis of Biotech stocks
- Full transcripts of recent conference calls in the Biotech sector
- Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?
By SA Editors
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Symbols:
-
Editor's Picks
-
Most Popular
- Assurant Is A Compelling Short Sell
- Broadcom Enters FTTH Chipset Market
- Another Macroshares Oil Arbitrage Opportunity
- Freeport McMoran: With Copper Prices Rising, It's Still a Buy
- Oil and the Futures Market
- Three Ways to Cash In on Record Meat and Dairy Prices
- Full list of Editor's Picks »
- High Likelihood of a Market Crash »
- Time To Start Buying Some Dogs? »
- Sirius-XM Combination: A Future Microsoft Acquisition? »
- JP Morgan Offer for Wachovia Makes Sense »
- High-Yield Canadian Royalty Trusts: What's the Catch? »
- Adding to My GE Position »
- 7 Stocks for a High Yield Cash Flow Portfolio »
- Drybulk Shipping: Prepare for a New Record High »
- Nokia: Bargain of a Lifetime - Barron's »
- Top 10 Payout Yield Stocks »
- Wall Street Breakfast: Must-Know News »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Gross Margin Drivers at Potash Corp. (Part II)
- A New Strategy for EXACT Sciences
- Cytori Therapeutics: The Stem Cell 'Celution' for Success
- LDK Solar: The Brightest Opportunity?
- Big Lots, Wal-Mart and Costco: 3 Musketeers of the Pooring of America
- What's Behind Hansen's Smackdown?
- The Long Case for China Medical Technologies
- ASA Limited: A Golden Opportunity
- ValueClick: Has the Hunted Become the Hunter?
- Petrohawk and Chesapeake Fly on Haynesville Shale News
- Full list of Long Ideas »
- Crystal River’s Q2 Write-Downs Could Bankrupt the Company
- Assurant Is A Compelling Short Sell
- Fuel Systems Solutions: Time to Take Profits
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Pair Trade Visa and Capital One
- Amazon's Kindle Numbers: All Fluff, Zero Substance
- A. Schulman: Cashless Profits
- Titan Machinery: Doesn't Anybody Look at Valuation?
- Goodrich Petroleum: Gas in the Ground Doesn't Mean Cash in the Bank
- Outlook Remains Grim for MBIA, Ambac
- Full list of Short Ideas »
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Momentum Stocks Stalled - Cramer's Stop Trading! (7/3/08)
- Expecting a Lift for Pediatrix: Cramer's Mad Money (7/3/08)
- The Most Bullish Thing - Cramer's Stop Trading! (7/1/08)
- Exelon's Got Nukes - Cramer's Lightning Round (7/1/08)
- Prescription Prediction for Allscripts - Cramer's Mad Money (7/1/08)
- Rex Marks the Spot - Cramer's Lightning Round, (6/30/08)
- Medicare Bill Buys - Cramer's Mad Money (6/30/08)
- Cracker Bottom of the Barrel - Cramer's Lightning Round (6/27/08)
- Britannia Bulk Rules the Waves - Cramer's Mad Money (6/27/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email